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Abstract 
Background 
Echocardiographic left atrial (LA) strain parameters have been associated with atrial 
fibrillation (AF) in prior studies. Our goal was to determine if strain measures [peak systolic 
longitudinal strain (LAS) and stiffness index (LASt)] changed after cardioversion (CV); and 
their relation to AF recurrence. 
Methods and results 
46 participants with persistent AF and 41 age-matched participants with no AF were 
recruited. LAS and LASt were measured before and immediately after CV using 2D speckle 
tracking imaging (2DSI). Maintenance of sinus rhythm was assessed over a 6-month follow 
up. Mean LAS was lower, and mean LASt higher, in participants with AF before CV as 
compared to control group (11.9 ± 1.0 vs 35.7 ± 1.7, p<0.01 and 1.31 ± 0.17 vs 0.23 ± 0.01, 
p<0.01, respectively). There was an increase in the mean LAS immediately after CV (11.9 ± 
1.0 vs 15.9 ± 1.3, p<0.01), whereas mean LASt did not change significantly after CV 
(p=0.62). Although neither LAS nor LASt were independently associated with AF recurrence 
during the follow-up period, change in LAS after cardioversion (post-CV LAS – pre-CV 
LAS) was significantly higher among individuals who remained in sinus rhythm when 
compared to individuals with recurrent AF (3.6 ± 1.1 vs 0.4 ± 0.8, p=0.02). 
Conclusions 
LAS and LASt differed between participants with and without AF, irrespective of the rhythm 
at the time of echocardiographic assessment. Baseline LAS and LASt were not associated 
with AF recurrence. However, change in LAS after CV may be a useful predictor of recurrent 
arrhythmia. 
Keywords 
Arrhythmia, Echocardiography, Strain, Stiffness 
Introduction 
Atrial fibrillation (AF) is the most common arrhythmia encountered, and the population 
burden of AF is increasing [1-7]. Pathological atrial structural remodeling characterized, by 
fibrosis and myofiber disarray, plays a critical role in AF initiation and maintenance [1,8-10]. 
Increased left atrial (LA) size on echocardiogram is associated with incident AF, recurrent 
AF, stroke and mortality [4,11-15]. Nevertheless, LA size only slightly improves AF risk 
prediction [16]. More recently, atrial myocardial deformation properties measured as strain, 
strain rate and stiffness (E/E’/strain) by tissue Doppler Imaging (TDI) and 2D speckle 
tracking imaging (2DSI) have shown promise as markers of atrial structural remodeling and 
as predictors of AF [1-5,17-19]. 2DSI measures local atrial myocardial deformation and 
unlike TDI, is angle independent, and unaffected by cardiac translation or tethering effect 
[4,15]. 
Preliminary work suggests that LA strain parameters are independent predictors of recurrence 
of AF in subjects undergoing cardioversion (CV) or catheter ablation [6,9,20-22]. The 
purpose of this prospective investigation was to determine if LA stiffness index (LASt), 
and/or peak systolic longitudinal LA strain (LAS) changed after CV in subjects with 
persistent AF; and their relation as predictors of maintenance of sinus rhythm. To our 
knowledge, this is the first study evaluating the role of LASt in AF recurrence after CV. 
Methods 
Patient population 
This study was approved by the University of Massachusetts Medical School Institutional 
Review Board. Between June of 2010 and May of 2011, 46 participants with persistent AF 
(duration of less than 12 months) undergoing a clinically indicated elective CV for AF and 41 
age-matched controls were recruited. Written-informed consent was obtained prior to 
enrollment. Exclusion criteria were: history of prior cardiac surgery, history of atrial flutter, 
history of paced atrial or ventricular rhythm, history of aortic or mitral valvular prosthesis, 
history of significant (moderate or greater) mitral insufficiency or stenosis, history of atrial or 
ventricular thrombus, history of atrial septal defect, pregnancy, age less than 18, inability to 
give consent and failure of CV. Five participants were excluded from the study since they 
failed cardioversion. Control subjects were subjects who had undergone an echocardiogram 
for varied indications but had no history of AF. A standard 2-Dimensional (2D) transthoracic 
echocardiography (TTE) was performed prior to elective CV and was repeated within 24 h 
post-CV in sinus rhythm. CV was performed as per ACC/AHA/ESC guidelines with direct-
current, synchronized shock in fasting subjects after intravenous sedation [23]. 
Echocardiography 
A standard TTE was performed using a Vivid 7 (GE Healthcare, Waukesha, WI) and a 
1.7/3.4 MHz tissue harmonic transducer with a frame rate of at least 50 frames per second. 
Machine settings were manually adjusted to optimize 2D endocardial and myocardial gray 
scale definition. Care was taken to obtain true apical images using standard anatomic 
landmarks in each view and not foreshorten the left ventricle or left atrium. All images were 
acquired at end-expiratory apnea. Loops of 5 cardiac cycles were stored digitally and 
analyzed offline using a customized software package (EchoPAC, GE Healthcare). 
Two-dimensional and Doppler echocardiographic variables 
LA diameter (LAD) was measured at end-systole along the parasternal long-axis view. 
Maximum LA volume (end-ventricular systole) was calculated from apical 4- and apical 2-
chamber views of the LA using the biplane method of disks, as is recommended by the 
American Society of Echocardiography [24]. Left ventricular end-systolic volume, left 
ventricular end-diastolic volume, and left ventricular ejection fraction (LVEF) were 
measured. Mitral flow velocity (E) was assessed by pulsed-wave Doppler from the apical 4 
chamber view by placing a sample volume between the tips of the mitral leaflets in diastole 
and recording at a sweep speed of 100 mm/s. Peak flow velocities were measured and 
averaged from five consecutive cycles. The average of lateral and medial mitral annulus early 
diastolic velocity (E’) was measured using TDI. The E/E’ ratio was used to estimate filling 
pressures [25]. 
Speckle tracking imaging 
Offline 2DSI technique was used to calculate LAS in individual LA regions. For 2DSI, a line 
was manually drawn along the LA endocardium at peak systole corresponding with the aortic 
valve closure. The software then automatically generated additional lines near the atrial 
epicardium, with a region of interest default width that was manually adjusted. Before 
processing, a cine loop preview feature was utilized to visually confirm that the internal line 
follows the LA endocardium throughout the cardiac cycle. If tracking of the LA endocardium 
was found to be unsatisfactory, then manual adjustments or changing software parameters 
(eg, region of interest size or smoothing functions) were made. For analysis of the LAS, 
region of interest was divided into 6 segments of the LA wall in each 4 and 2 chamber views 
and were manually tracked frame by frame to maintain the position within the LA wall. LAS 
was measured at each segment divided from the annulus to the roof of LA (Figure 1). The 
LAS of the 6 segments was averaged for analysis. Approximately 90.5% of the individual 
segments throughout the study had adequate speckle tracking, and were included for strain 
analysis. The other 9.5% of the individual segments had inadequate speckle tracking due to 
either poor image quality or pulmonary vein openings, and were excluded from the analysis. 
Inter-observer variability expressed as a coefficient of variation, was assessed by analyzing 
10 randomly chosen subjects by 2 independent investigators. For intra-observer variability, 
10 randomly chosen participants were analyzed by the same investigator twice with a 
minimum gap of a month. The intra-observer and inter-observer variability for LAS were 4% 
and 7% respectively, and for LASt were 5% and 7% respectively. 
Figure 1 Assessment of peak systolic longitudinal left atrial strain (LAS) by 2D speckle 
tracking imaging (2DSI) 
In a recent study the validity and accuracy of LASt was examined using both invasive LA 
pressure, and non-invasive surrogates of left atrial pressure (E/A, E/E’, and E/Vp) [21]. The 
calculation of LASt using E/E’ had closest correlation to LASt derived by invasive LA 
pressures [21]. In our study we calculated the LASt as (E/E’/LAS). 
Atrial fibrillation 
AF at baseline was diagnosed on a 12-lead electrocardiogram. All participants were 
discharged with a 30-day continuous electrocardiography recording monitor (Heartrak 
ECAT(External Cardiac Ambulatory Telemetry); AMI Cardiac Monitoring; Sandy Spring, 
Maryland) after CV. Any abnormal electrical activity recordings were transmitted to the 
electrophysiologist on a daily basis even if not triggered by subjects and asymptomatic. All 
AF recurrences were adjudicated by an experienced cardiac electrophysiologist (DDM). 
Using an electronic medical record chart review, subjects were followed for 6 months for 
interim hospitalizations, emergency room visits and outpatient visits. Any evidence of AF 
based on electrocardiographic findings was considered as recurrence. 
Statistical analysis 
The data were initially analyzed for normality. Chi square tests for categorical variables and 
Student’s t test for continuous variables were used to examine potential differences between 
study groups. Wilcoxon rank sum test for paired variables and Mann–Whitney U test for 
unpaired variables were used for data that did not have a normal distribution. Ordinal 
variables were tabulated as mean ± 2 SEM or with the confidence intervals of 5th and 95th 
percentiles. 
Area under the Receiver Operating Curve (ROC), univariate and multivariate analysis were 
performed to describe the prognostic value of strain parameters for prediction of sinus rhythm 
maintenance after CV. Cutoff for p values in univariate analysis was 0.3 to enter multivariate 
analysis; and was considered statistically significant in multivariate analysis only if p was < 
0.05. Sensitivity, specificity and optimal cut-off values were determined from the ROC curve 
data. All the analyses were performed with commercially available packages for (SPSS, 
Version 20.0, SPSS Inc., Chicago, IL, USA; and GraphPad Prism version 5.00 for Windows, 
GraphPad Software, San Diego, California, USA). 
Results 
Clinical characteristics of AF and controls 
The general clinical characteristics are recorded in Table 1. Subjects in AF group were 
predominantly male, and had a higher incidence of obesity, hypertension and heart failure as 
compared to the control group. 
Table 1 Baseline clinical characteristics of patients with atrial fibrillation (AF) as 
compared to the control group 
 AF (41) n (%) Controls (41) n (%) P value 
Mean age (years) 64.5 ± 4.0 61.7 ± 2.4 0.12 
Sex (M/F) 29/12 13/28 <0.01 
BMI (Kg/m2) 32.5 ± 2.3 25.8 ± 1.6 <0.01 
Comorbid conditions: 
HTN 30 (73.2) 16 (39) <0.01 
CAD 14 (34.1) 4 (9.7) <0.01 
Systolic HF 13 (31.7) 0 <0.01 
CVA 1 (2.4) 0 1.0 
DM 11 (26.8) 4 (9.7) 0.08 
Dyslipidemia 24 (58.5) 9 (21.9) <0.01 
Medications: 
Statins 22 (53.6) 6 (14.6) <0.01 
Beta blockers 27 (65.8) 9 (21.9) <0.01 
ACE-i/ARB 24 (58.5) 8 (19.5) <0.01 
CCB 17 (41.5) 5 (12.2) <0.01 
Digoxin 4 (9.7) 0 0.11 
Diuretics 21 (51.2) 5 (12.2) <0.01 
ASA 30 (73.2) 5 (12.2) <0.01 
Clopidogrel 2 (4.8) 0 0.49 
Warfarin 28 (68.3) 3 (7.3) <0.01 
Heparin 4 (9.7) 0 0.11 
Amiodarone 8 (19.5) 0 <0.01 
Sotalol 5 (12.2) 0 0.05 
Other anti-arrhythmics 4 (9.7) 0 0.11 
BMI – Body Mass Index, HTN – Hypertension, CAD – Coronary artery disease, HF- Heart 
failure, DM – Diabetes Mellitus, CVA – Cerebrovascular accident, ACE-i/ARB – 
Angiotensinogen converting enzyme inhibitors/Angiotensin receptor blockers, CCB – 
Calcium channel blockers, ASA - Aspirin 
Comparison of echocardiographic and strain parameters in AF and controls 
pre and post CV 
The echocardiographic variables and strain parameters in participants with AF and controls 
with no history of AF are displayed in Table 2. Mean LAS was significantly lower in subjects 
with AF, pre-CV as compared to the control group (11.9 ± 1.0 vs 35.7 ± 1.7, p<0.01) (Figure 
2). Mean LAS was lower (15.9 ± 1.3 vs 35.7 ± 1.7, p <0.01), and mean LASt higher (1.1 ± 
0.3 vs 0.2 ± 0.01, p<0.01), in participants with AF after CV as compared to participants with 
no history of AF (Figure 2). Among participants with AF, there was a significant increase in 
mean LAS (11.9 ± 1.0 vs 15.9 ± 1.3, p<0.01), but no change in LASt (p=0.62), after CV 
(Figure 3). 
Table 2 Echocardiographic and strain variables of patients with atrial fibrillation (AF) 
as compared to the control group 
Echo variables AF (n=41) Controls (n=41) P value 
LVIDd, mm 50.2 ± 2.6 44.8 ± 1.8 <0.01 
LVIDs, mm 35.6 ± 3.2 28.0 ± 1.8 <0.01 
STd, mm 10 ± 0.6 8.9 ± 0.6 <0.01 
PWTd, mm 10 ± 0.6 8.1 ± 0.6 <0.01 
LVEF (%) 54.0 ± 3.6 65.1 ± 1.0 <0.01 
LAD, mm 45.9 ± 4.0 33.4 ± 2.0 <0.01 
LAVI, ml/M2 34.7 ± 4.0 23.4 ± 3.2 <0.01 
E/E’ 10.7 ± 1.8 7.6 ± 0.8 <0.01 
 Pre- CV Post- CV P value   
2CLAS, % 12.7 (10.2 – 15.2) 16.5 (13.2 – 19.9) 0.01 38.3 (33.1 – 43.5) <0.01 
4CLAS, % 11.0 (8.6 – 13.5) 15.2 (12.4 – 18.0) <0.01 33.1 (29.6 – 36.6) <0.01 
LAS, % 11.9 (9.8 – 13.9) 15.9 (13.1 – 18.7) <0.01 35.7 (32.1 – 39.3) <0.01 
2CLASt 1.06 (0.81 – 1.32) 1.25 (0.16 – 2.33) 0.67 0.24 (0.19 – 0.28) <0.01 
4CLASt 1.57 (1.04 – 2.10) 0.85 (0.61 – 1.09) 0.02 0.24 (0.20 – 0.28) <0.01 
LASt 1.32 (0.97 – 1.67) 1.05 (0.44 – 1.66) 0.62 0.23 (0.19 – 0.27) <0.01 
LVIDd – Left ventricular internal diameter at end- diastole, LVIDs – Left ventricular internal 
diameter at end- systole, STd – Interventricular septum thickness at end-diastole, PWTd – 
Left ventricular posterior wall thickness at end-diastole, LVEF – Left ventricular ejection 
fraction, LAD – Left atrial diameter, LAVI – Left atrial volume index, E = early filling 
velocity of transmitral Doppler flow, E’ = Average early diastolic velocity of medial and 
lateral mitral annulus, 2CLAS - 2 chamber average peak systolic strain, 4CLAS - 4 chamber 
average peak systolic strain, LAS – Mean peak systolic strain of 2C and 4C, 2CLASt - 2 
chamber left atrial stiffness, 4CLASt – 4 chamber left atrial stiffness, LASt – Mean left atrial 
stiffness of 2C and 4C 
Figure 2 Comparison of mean LAS (left) and of left atrial stiffness index (LASt) (right) 
at baseline between the AF group and control group 
Figure 3 Comparison of mean LAS (left panel) and of LASt (right panel) in subjects 
with AF pre and post cardioversion (CV) 
Clinical characteristics of the maintained sinus rhythm (MSR) and AF 
recurrence (AFR) groups 
Twenty-seven (66%) of participants undergoing CV for persistent AF remained in normal 
sinus rhythm throughout the 6-month follow-up period, whereas 14 (34%) experienced at 
least 1 recurrence of AF. There was no significant difference in age, sex, body mass index 
(BMI), comorbidities or medications, especially anti-arrhythmic drugs between both the 
groups (Table 3). Three out of fourteen subjects had AF recurrence within 24 h. Eight out of 
fourteen subjects had AF recurrence within 30 days. The remaining three subjects had AF 
recurrence between one and six months. Amongst the subjects who had a recurrence within 
30 days, the mean AF burden was 46.13%. None of the study subjects had new onset stroke 
or transient ischemic attack during the 6 month follow up. 
Table 3 Baseline clinical characteristics of patients in the maintained sinus rhythm 
(MSR) group as compared to the atrial fibrillation recurrence (AFR) group 
 MSR (27) n (%) AFR (14) n (%) P value 
Mean age (years) 65 ± 5.0 64 ± 6.8 0.9 
Sex (M/F) 21/6 8/6 0.28 
BMI (Kg/m2) 32 ± 3.0 34 ± 3.6 0.26 
Comorbid conditions:    
HTN 21 (77.8) 12 (85.7) 0.69 
CAD 9 (33.3) 5 (35.7) 1.0 
Systolic HF 11 (40.7) 3 (21.4) 0.3 
CVA 0 (0) 1 (7.1) 0.34 
DM 5 (18.5) 6 (42.8) 0.14 
Dyslipidemia 16 (59.2) 8 (57.1) 1.0 
Medications:    
Statins 14 (51.8) 8 (57.1) 1.0 
Beta blockers 20 (74.1) 7 (50.0) 0.17 
ACE-i/ARB 14 (51.8) 11 (78.5) 0.17 
CCB 12 (44.5) 6 (42.8) 1.0 
Digoxin 2 (7.4) 2 (14.3) 0.59 
Diuretics 16 (59.2) 5 (35.7) 0.19 
ASA 18 (66.7) 12 (85.7) 0.28 
Clopidogrel 1 (3.7) 1 (7.1) 1.0 
Warfarin 18 (66.7) 10 (71.4) 1.0 
Heparin 1 (3.7) 3 (21.4) 0.11 
Amiodarone 7 (25.9) 1 (7.1) 0.23 
Sotalol 2 (7.4) 3 (21.4) 0.32 
Other anti-arrhythmics 3 (11.1) 1 (7.1) 1.0 
BMI – Body Mass Index, HTN – Hypertension, CAD – Coronary artery disease, HF- Heart 
failure, DM – Diabetes Mellitus, CVA – Cerebrovascular accident, ACE-i/ARB – 
Angiotensinogen converting enzyme inhibitors/Angiotensin receptor blockers, CCB – 
Calcium channel blockers, ASA - Aspirin 
Comparison of echocardiographic and strain parameters in the MSR and 
AFR group 
The echocardiographic variables and strain parameters of MSR and AFR groups are recorded 
in Table 4. There was no significant difference in mean pre-CV LAS between both the groups 
(11.8 ± 1.3 vs 12.0 ± 1.6, p=0.95). Mean post-CV LAS was higher in the MSR group as 
compared to the AFR group (17.0 ± 1.8 vs 13.5 ± 1.7, p=0.19). In the MSR group, mean LAS 
after CV was higher as compared to the pre-CV LAS (11.8 ± 1.3 vs 17.0 ± 1.8, p<0.01). In 
contradistinction, participants who had a recurrence of AF had no significant change in LAS 
after CV (12.0 ± 1.6 vs 13.5 ± 1.7, p=0.38) (Figure 4). Difference in mean LAS after CV was 
statistically significant in the MSR group as compared to the AFR group (3.6 ± 1.1 vs 0.4 ± 
0.8, p=0.02). There was no significant change in mean LASt after CV in either the MSR or 
the AFR group (1.28 ± 0.22 vs 1.12 ± 0.41, p=0.92; 1.38 ± 0.26 vs 0.87 ± 0.18; p=0.22) 
respectively. 
Table 4 Echocardiographic and strain variables of patients with maintained sinus rhythm (MSR) group as compared to the atrial 
fibrillation recurrence (AFR) group 
Echo variables MSR (n=27) AFR (n=14) P value 
LVIDd, mm 49.6 ± 2.6 51.5 ± 6.6 0.68 
LVIDs, mm 35.8 ± 3.6 35.2 ± 6.6 0.84 
STd, mm 10.4 ± 0.8 10.5 ± 0.8 0.61 
PWTd, mm 10.1 ± 0.8 10.8 ± 1.0 0.18 
LVEF (%) 54.8 ± 4.4 52.5 ± 7.0 0.72 
LAD, mm 46.5 ± 3.8 44.7 ± 9.4 0.95 
Pre-CV LAVI, ml/M2 34.5 ± 5.0 36.5 ± 5.6 0.82 
Post-CV LAVI, ml/M2 35 ± 5.6 34.2 ± 5.2 0.89 
E/E’ 9.8 ± 2.2 12.5 ± 2.6 0.07 
 Pre-CV Post-CV P value Pre-CV Post-CV P value 
HR 84.0 (77.6 – 90.6) 66.0 (60.5 – 71.6) <0.01 87.9 (78.2 – 97.6) 75.7 (69.3 – 82.1) 0.05 
LAVI, ml/M2 34.5 (29.4 – 39.8) 35 (29.2 – 40.9) 0.87 36.5 (30.9 – 42.1) 34.2 (29.0 – 39.4) 0.19 
2CLAS, % 12.8 (9.5 – 16.3) 18.0 (13.4 – 22.8) 0.01 12.4 (8.1 – 16.8) 13.2 (10.7 – 15.8) 0.68 
4CLAS, % 10.8 (7.6 – 14.1) 15.9 (12.5 – 19.3) <0.01 11.6 (7.5 – 15.7) 13.7 (7.7 – 19.9) 0.75 
LAS, % 11.8 (9.1 – 14.6) 17.0 (13.2 – 20.8) <0.01 12.0 (8.3 – 15.7) 13.5 (9.5 – 17.6) 0.38 
2CLASt 0.92 (0.63 – 1.20) 1.42 (−0.16 – 2.99) 0.5 1.32 (0.78 – 1.87) 0.83 (0.52 – 1.14) 0.25 
4CLASt 1.64 (0.86 – 2.41) 0.83 (0.54 – 1.12) 0.06 1.45 (0.78 – 2.13) 0.92 (0.32 – 1.52) 0.24 
LASt 1.28 (0.81 – 1.76) 1.12 (0.25 – 1.99) 0.92 1.39 (0.81 – 1.97) 0.88 (0.43 – 1.33) 0.22 
LVIDd – Left ventricular internal diameter at end- diastole, LVIDs – Left ventricular internal diameter at end- systole, STd – Interventricular 
septum thickness at end-diastole, PWTd – Left ventricular posterior wall thickness at end-diastole, LVEF – Left ventricular ejection fraction, 
LAD – Left atrial diameter, LAVI – Left atrial volume index, E = early filling velocity of transmitral Doppler flow, E’ = Average early diastolic 
velocity of medial and lateral mitral annulus, HR – Heart rate, 2CLAS - 2 chamber average peak systolic strain, 4CLAS - 4 chamber average 
peak systolic strain, LAS – Mean peak systolic strain of 2C and 4C, 2CLASt - 2 chamber left atrial stiffness, 4CLASt – 4 chamber left atrial 
stiffness, LASt – Mean left atrial stiffness of 2C and 4C 
Figure 4 Post-CV mean LAS as compared to pre-CV mean LAS in the maintained sinus 
rhythm group (MSR) versus the atrial fibrillation recurrence group (AFR) 
LAS and LASt as predictors for maintenance of sinus rhythm 
A regression analysis adjusted for age, sex and BMI was performed initially and showed that 
difference in strain (post-CV LAS – pre-CV LAS) was a predictor of maintenance of sinus 
rhythm (B coefficient 3.1, p=0.09). Further multivariate regression adjusting for age and 
BMI, demonstrated that the difference in strain showed a trend towards prediction of MSR (B 
coefficient 3.7, p = 0.08) (Table 5). ROC curves were plotted for pre-CV LAS (AUC 0.52 ± 
0.09), post-CV LAS (AUC 0.38 ± 0.09) and difference in strain (AUC 0.38 ± 0.09). ROC 
curves for pre-CV LASt had an AUC of 0.43 ± 0.08. 
Table 5 Univariate and Multivariate predictors of maintenance of sinus rhythm in 
patients with atrial fibrillation (AF) after cardioversion 
Parameter Univariate regression 
B co-efficient P value 
Age 2.3 0.53 
Sex −0.2 0.14 
BMI −2.4 0.35 
Pre-CV LAVI 2.3 0.65 
Difference in LAVI −2.8 0.44 
Pre-CV HR −0.01 0.99 
Difference in HR 7.3 0.27 
Pre-CV LAS 0.06 0.98 
Difference in LAS 3.1 0.09 
Pre-CV LASt −0.2 0.55 
Difference in LASt 0.5 0.59 
 Multivariate regression 
 B co-efficient P value 
Sex −0.2 0.32 
Difference in HR 4.7 0.49 
Difference in LAS 3.7 0.08 
Discussion 
In this prospective clinical study involving 82 participants, we found that mean LAS was 
lower and mean LASt higher in subjects with AF as compared to those in normal sinus 
rhythm and no history of AF. We also observed that, although mean LAS improved 
immediately after CV in subjects with AF, it failed to normalize completely and remained 
lower in subjects with a history of AF than the control group. Mean LASt did not 
significantly change after CV. Compared with individuals who experienced a recurrence of 
AF over the follow-up period, those who remained in normal sinus rhythm were more likely 
to experience a significant improvement in the LAS after CV. Difference in strain (post-CV 
LAS – pre-CV LAS) showed a trend towards prediction of maintenance of sinus rhythm after 
cardioversion. 
Atrial myocardial deformation properties and AF 
Normal LA function comprises three components: reservoir function, serving to store blood 
from the pulmonary veins; conduit function, wherein blood passes through the left atrium 
from the pulmonary veins to the left ventricle in early diastole; and booster function, where 
atrial contraction serves to increase end diastolic ventricular fiber stretch [2]. Several studies 
have demonstrated that atrial structural remodeling during AF is due to a variable degree of 
fibrosis, atrial myocyte hypertrophy, myofiber disarray and apoptosis [8,10]. Atrial strain 
parameters have been proven to correlate significantly with the underlying fibrosis and have 
been validated against sonomicrometry and tagged MRI, thus providing a comprehensive real 
time quantitative assessment of regional atrial myocardial deformation [15,26]. However, 
strain and strain rate can be influenced by loading conditions and may be influenced by 
rhythm irregularity, irrespective of degree of underlying fibrosis [3,9]. 
Preliminary work suggests that LA strain parameters are independent predictors of recurrence 
of AF in subjects undergoing cardioversion (CV) or catheter ablation [6,9,20-22]. 
Accordingly, the study was undertaken to better understand to what extent systolic strain is 
influenced by the atrial rhythm. We also evaluated the role of these strain variables in 
predicting the recurrence of AF. 
Recovery of left atrial function after CV and re-established sinus rhythm 
Our finding that LAS was significantly lower in subjects with AF as compared to controls 
was similar to the findings of prior studies [3,4,6,22]. As has previously been reported in the 
published literature, LAS increased significantly immediately after CV. However, mean LAS 
did not normalize completely [6,7,27,28]. This is consistent with the findings of a 3-year 
follow-up study, which demonstrated that although the LA contractility improved after 
successful CV, it remained modestly impaired [27]. In contrast to this work, however, we 
measured LAS immediately after CV instead of 1 month after CV. The improvement in LA 
strain after CV or catheter ablation has been previously attributed to ‘reverse atrial 
remodeling [27]. The immediate improvement in LAS after cardioversion in individuals with 
AF enrolled in our study makes structural remodeling less likely and restoration of atrial 
contraction as the more likely cause of the change in LAS. The fact that LAS measured 
immediately after CV did not improve to levels seen among individuals with no history of AF 
could have resulted from “atrial stunning” or from persistent mechanical and/or LA structural 
abnormalities. 
As has been previously reported [21], baseline LASt was significantly higher among 
participants with AF as compared to participants with no AF, likely secondary to decreased 
LA compliance in subjects with AF. Interestingly, there was no change in LASt immediately 
after CV. In comparison with LAS, the fact that LASt values were similar in AF and after 
cardioversion in sinus rhythm, suggests that LASt is a more reliable index of the underlying 
structural characteristics of the LA than LAS. Stiffness being directly proportional to LA 
size, it is not surprising that LASt did not change in the short term, as there was no 
opportunity for reverse remodeling of the LA. 
Prediction of maintenance of sinus rhythm 
The degree of impairment in atrial compliance, as assessed by LAS, has been reported to 
relate to maintenance of sinus rhythm after CV or catheter ablation in subjects with persistent 
AF [2,3,6,9]. However, our study findings showed no significant difference for the pre- and 
post-CV LAS and LASt values between the MSR and AFR group. Also unlike prior studies, 
we did not find baseline LAS or LASt to be an independent predictor of maintenance of sinus 
rhythm [21]. We found that the change in LAS was associated with maintenance of sinus 
rhythm. Although our finding did not meet statistical significance, this finding was similar to 
Schneider et al. who also demonstrated that LAS increased in subjects with MSR during a 
three month follow up in contrast to subjects with AFR [6]. Due to the low rates of post-
conversion recurrent AF, we acknowledge that further studies are needed in order to have the 
appropriate statistical power to address this issue. 
The results of our study could be influenced by several factors. Even though we used a 
continuous event monitor for one month, we could have missed asymptomatic AF 
recurrences between month two to six of follow-up. The duration of persistent AF may have 
played a role in altering the predictive probability of strain for AF recurrence. In contrast to 
our study, which only included participants with persistent AF, most of the studies that have 
shown that lower LAS is associated with higher recurrence rates have recruited subjects with 
both paroxysmal and persistent AF. Since Schneider et al. have reported lower strain values 
in subjects with persistent AF as compared to paroxysmal AF, it is possible that our exclusion 
of participants with paroxysmal AF may have influenced our findings [6]. Also, the platform 
utilized to analyze strain variables can possibly influence the magnitude of the strain values 
thus leading to differing results. Evaluation of LASt and LAS in a larger sample of 
participants with both paroxysmal and persistent AF is warranted to more fully evaluate the 
potential associations between LA strain measures and AF recurrences. 
Study limitations 
A long-term prospective study with repeated strain measurement over time would be ideal to 
assess the effects of reverse atrial modeling on strain and stiffness. Studies with larger sample 
size with subgroup analysis of paroxysmal and persistent AF would be beneficial in further 
evaluating role of strain as predictive markers for AF recurrence. 
Clinical implication 
Recent studies suggest LA strain as a predictor of stroke risk and cardiovascular outcomes in 
patients with AF [29,30]. A better understanding of atrial physiology might potentially permit 
targeted strategies to prevent AF recurrence, thereby decreasing the risk of major adverse 
cardiovascular outcomes. While baseline atrial strain does not appear to be a predictor of the 
maintenance of sinus rhythm, our data do suggest the hypothesis that improvement in strain 
following CV is a favorable prognostic sign. 
Conclusion 
We observed that LAS and LASt differed between participants with and without AF, 
irrespective of the rhythm at the time of echocardiographic assessment; to our knowledge, 
ours is the first study analyzing left atrial stiffness index before and after cardioversion. 
Unlike prior studies, we did not find LAS or LASt at baseline to be an independent predictor 
of AF recurrence. However, our results suggest that change in LAS after CV may be a useful 
predictor of recurrent arrhythmia. Further long term follow up studies are required to 
establish the role of this stiffness index utilizing non-invasive surrogate markers of left atrial 
filling pressure. 
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